Clinical trials
Glaucoma Eye clinical trials
Below are recruiting glaucoma eye clinical trials, each written for real people, not researchers. We’re tracking 46 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04381611Enrolling by invitation
Study of glaucoma surgeries and laser treatments over time
This study looks at people with glaucoma or high eye pressure to understand how surgeries and laser treatments affect long-term outcomes. It may help doctors predict which treatments work best for different patients.
Lausanne, Canton of VaudAges 1–100 - NCT05685485Recruiting
Testing a tube implant surgery for certain glaucoma
This trial studies a glaucoma operation that uses an Ahmed valve tube implant. It may help people whose eye pressure is not well controlled with current treatments by comparing outcomes of this specific surgical approach.
St Louis, MissouriAges 18 years+ - NCT07303257Recruiting
Quality of life after glaucoma surgery: a patient-centered study
This study compares how different types of glaucoma surgery affect your daily life and well-being. If you need glaucoma surgery, you may join to help doctors understand which procedure works best from a patient's perspective.
LyonAges 18 years+ - NCT06934577Recruiting
Glaucoma screening and eye health study via telemedicine
This study tests if telemedicine can help find glaucoma and other eye problems early. It may help people who speak one of several languages and want to check their eye health from home.
Flint, MichiganAges 18 years+ - NCT07780916Recruiting
Long-term results of trabeculotomy for glaucoma
This study looks at how well a specific type of glaucoma surgery (ab-interno trabeculotomy with the Trabectome device) works over the long term. If you had this surgery at the University Hospital Würzburg between 2019 and 2021, researchers will review your records and check your eye health at a study visit. This could help doctors understand the surgery's effectiveness and safety over time.
Würzburg, BavariaAges 18 years+ - NCT06607705Recruiting
Eye pressure changes after iStent surgery with a contact lens sensor
This study tests a tiny implant (iStent inject W) that helps lower eye pressure in people with open-angle glaucoma. A special contact lens sensor will monitor your eye pressure after surgery. The goal is to see how well the implant works and how it changes your eye pressure throughout the day.
Barcelona, SpainAges 18 years+ - NCT07396441RecruitingPhase 4
Kelulut honey therapy for juvenile glaucoma
This trial tests if adding Kelulut honey to standard treatment can help protect the optic nerve in young people with juvenile open-angle glaucoma. It looks at eye pressure, nerve thickness, and dry eye symptoms.
Kota Bharu, KelantanAges 15–40 - NCT07327242Enrolling by invitation
AI tool to improve eye test accuracy in glaucoma patients
This trial tests if a large language model tool can help patients perform more reliable visual field tests. It may improve detection of glaucoma progression.
Palo Alto, CaliforniaAges 18 years+ - NCT07243665Recruiting
Glaucoma screening with AI for diabetes patients
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
Singapore, SingaporeAges 21 years+ - NCT05401357RecruitingPhase 3
Test eye drops for glaucoma or high eye pressure in both eyes
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
Newport Beach, CaliforniaAges 18 years+ - NCT06017362RecruitingPhase 4
Insulin drops for dry eye in glaucoma patients
This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.
Madrid, MadridAges 18 years+ - NCT06267274RecruitingPhase 1
Comparing two forms of bimatoprost for glaucoma or high eye pressure
This trial tests whether a new formulation of bimatoprost works as well as an existing one to lower eye pressure in people with chronic open-angle glaucoma or ocular hypertension. It involves multiple eye drop doses and checks for safety and effectiveness.
Bakersfield, CaliforniaAges 18 years+ - NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05710198RecruitingPhase 3
Citicoline eye drops to slow vision field loss in glaucoma
This Phase 3 trial tests whether citicoline 2% eye drops can help slow worsening of the visual field in adults with open-angle glaucoma. If you qualify, you would be monitored with repeated eye tests to see if your vision field stays more stable over time.
Milan, MIAges 18 years+ - NCT04232982Recruiting
Cyclophotocoagulation during Boston keratoprosthesis eye surgery
This trial looks at whether a specific eye laser treatment done through the white of the eye (called transscleral cyclophotocoagulation) works well and is safe for people getting a Boston keratoprosthesis. It may help improve comfort and vision outcomes for selected patients needing this type of cornea/eye replacement surgery.
Montreal, QuebecAges 18–80 - NCT07780890Recruiting
Measuring eye hydration with light
This study uses a non-invasive imaging technique called Brillouin hydration mapping to measure hydration levels in different parts of the eye. It aims to help doctors better understand how hydration affects eye health and disease.
Boston, MassachusettsAges 20–79 - NCT07777861RecruitingPhase 2
Testing an eye drop for worsening glaucoma
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
Beijing, Beijing MunicipalityAges 18–80 - NCT06731582Enrolling by invitationPhase 3
Nicotinamide supplement study for glaucoma patients
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
Singapore, Central SingaporeAges 21 years+ - NCT07281391Recruiting
Laser treatment for pigmentary glaucoma
This trial tests a laser procedure called DSLT to lower eye pressure in people with pigmentary glaucoma. It may offer a treatment option for those who have not had prior glaucoma surgeries.
Houston, TexasAges Any age - NCT07520175Enrolling by invitation
Bio-Reinforced Canaloplasty for Open-Angle Glaucoma
This study tests a newer surgical procedure called bio-reinforced canaloplasty, which helps fluid drain better from the eye to lower eye pressure in people with open-angle glaucoma. Researchers will follow patients to see how well this procedure works and how safe it is.
Chico, CaliforniaAges Any age - NCT05180994RecruitingPhase 1/Phase 2
Infliximab eye drops after first corneal transplant
This trial tests infliximab—given as eye drops—after a first corneal transplant to see if it can improve healing and eye outcomes. It may help people at risk of inflammation after surgery, but it also requires careful screening for infection and medication safety.
Montreal, QuebecAges 18–80 - NCT06841575Recruiting
Better eye imaging for children and adults at Duke
This study tests a new camera that automatically adjusts to take clear pictures of the back of the eye. It aims to improve retinal imaging for healthy adults, adult eye clinic patients, and children seen at Duke Eye Center.
Durham, North CarolinaAges 1 month+ - NCT07390890Recruiting
DSLT to reduce glaucoma eye drops
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
Largo, FloridaAges Any age - NCT07147647Recruiting
Laser treatment for lowering eye pressure in Black patients with glaucoma
This trial tests a laser procedure called DSLT to reduce eye pressure in Black patients with mild to moderate open-angle glaucoma. It aims to see if this treatment works well as a first step before using eye drops.
Elkridge, MarylandAges 18 years+
Hear when a new Glaucoma Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for glaucoma eye?
- Yes. Clin2 currently lists 46 recruiting glaucoma eye studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glaucoma eye trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glaucoma eye trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.